A Study to Determine the Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles

Periorbital Hyperpigmentation (Dark Circles) Clinical Trial

Official title: A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate (HPL) for Treatment of Periorbital Hyperpigmentation (Dark Circles)

Status Active, not recruiting

Clinical Trial Summary

This is a multicentre, open label, randomized, pilot study to evalute safety and efficacy of Human Platelet Lysate (HPL) in subjects with Periorbital Hyperpigmentation. The study is being conducted at 2 centers in India.The primary endpoints are Physicians and Patient Self assessment score. The secondary endpoints are improvement in photographic assessment form randomization to end of study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Hyperpigmentation
• Periorbital Hyperpigmentation (Dark Circles)

• NCT number: NCT01644448
• Study type: Interventional
• Source: Kasiak Research Pvt. Ltd.
• Status: Active, not recruiting
• Phase: Phase 1/Phase 2
• Start date: March 2012
• Completion date: November 2012